Tardive dyskinesia by body region in subjects with schizophrenia/schizoaffective disorder or mood disorder: findings from the KINECT 3 study

被引：0
|
作者：
Factor, S.
Stacy, M.
Burke, J.
Yonan, C.
Le, H.
Liang, G.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
408
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Association of Per3 gene with bipolar disorder: comment on "Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia"
    Brasil Rocha, Paulo Marcos
    Neves, Fernando Silva
    Alvarenga, Nathalia Bueno
    Hughet, Rodrigo Barreto
    Barbosa, Izabela Guimaraes
    Correa, Humberto
    BIPOLAR DISORDERS, 2010, 12 (08) : 875 - 876
  • [22] EFFICACY AND SAFETY OF VALBENAZINE (NBI-98854) IN SUBJECTS WITH TARDIVE DYSKINESIA: RESULTS OF A LONG-TERM STUDY (KINECT 3 EXTENSION)
    Siegert, S.
    Factor, S.
    Liang, G.
    Burke, J.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E35 - E35
  • [23] Efficacy of Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia: Results of a Long-Term Extension Study (KINECT 3 Extension)
    Grigoriadis, Dimitri
    Comella, Cynthia
    Remington, Gary
    Jimenez, Roland
    Burke, Joshua
    Christopher, O'Brien
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S213 - S214
  • [24] Analysis of the clinical profile of patients with schizophrenia and schizoaffective disorder at the acute care unit (profile 3 study)
    San, L.
    Bernardo, M.
    de la Camara, A. Gomez
    Puig, C.
    Castillo, C.
    Rodriguez, A.
    EUROPEAN PSYCHIATRY, 2007, 22 : S107 - S107
  • [25] Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Peng, Xiaomei
    Kinon, Bruce J.
    Tohen, Mauricio
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) : 1580 - 1588
  • [26] Neurobiological Findings from a Ten-Year Prospective Longitudinal Study of Mood Disorder
    Whalley, Heather
    Nickson, Thomas
    Chan, Stella
    Romaniuk, Liana
    Lawrie, Stephen
    McIntosh, Andrew
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S318 - S318
  • [27] Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder
    Rossi, A.
    Bernareggi, M. M.
    Giustra, M. G.
    EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S167
  • [28] Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene:: is schizoaffective disorder special?
    Meszaros, K
    Lenzinger, E
    Hornik, K
    Füreder, T
    Stompe, T
    Willinger, U
    Heiden, A
    Fathi, N
    Gerhard, E
    Fuchs, K
    Sieghart, W
    Kasper, S
    Aschauer, HN
    PSYCHIATRY RESEARCH, 2000, 96 (02) : 179 - 183
  • [29] Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study
    Cullen, Bernadette A.
    Rodriguez, Katrina
    Eaton, William W.
    Mojtabai, Ramin
    Von Mach, Tara
    Ybarra, Michele L.
    PSYCHIATRY RESEARCH, 2020, 292
  • [30] Clinical maintenance response with risperidone long-acting injectable (rlai) in subjects with schizophrenia or schizoaffective disorder: A 52 weeks Italian study
    Rossi, A.
    Bernareggi, M. M.
    Giustra, M. G.
    EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S168
12345